Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Pacira Biosciences, Inc.
zimmerbiomet.comAI Executive Summary
AI-powered analysis of 8-K filing content
Pacira Biosciences divested its CryoTech subsidiary to Zimmer, Inc. for up to $140 million to streamline operations and focus on core business areas. This strategic divestiture removes a non-core asset and generates significant cash proceeds.
Key Takeaways
Pacira sold wholly owned subsidiary Pacira CryoTech, Inc. and related cryoanalgesia device assets including iovera® to Zimmer, Inc.
Total transaction value is up to $140 million with $70 million upfront payment and contingent consideration subject to typical adjustments
2 more takeaways